Seles’ first symptoms appeared suddenly around three years ago. She began having double vision and weakness in her arms and ...

Women with myasthenia gravis have higher rates of preterm birth and cesarean delivery, new findings show, underscoring the need for careful pregnancy management and monitoring.

Nipocalimab shows promise in treating myasthenia gravis in children, with ongoing trials revealing safety and efficacy similar to adult studies, says Jonathan Strober, MD.

Two open-label extension studies show that the FcRn blocker nipocalimab has durable efficacy and sustained symptom control ...

Results from the phase III VIBRANCE-MG study presented at the American Association of Neuromuscular & Electrodiagnostic Medicine annual meeting showed that nipocalimab (Imaavy) was safe and ...

1. Willi R, Bril V, Howard J, et al. RELIEVE: a phase 3 study evaluating the efficacy and safety of remibrutinb in generalized myasthenia gravis. Presented at: American Association of Neuromuscular & ...

Regeneron could be just a few months away from filing for approval of a therapy for the neuromuscular disorder generalised myasthenia gravis (gMG), cemdisiran, which can be dosed just four times a ...

A multidisciplinary panel of medical oncology, dermatology, gastroenterology, rheumatology, pulmonology, endocrinology, neurology, hematology, emergency medicine ...

Culligan offers water treatment solutions and systems. Its products and services include water softeners, filtration systems and bottled water delivery. Established in 1936, Culligan aims to use ...